Insulin resistance and Metabolic dysfunction-associated steatotic liver disease (MASLD): Pathways of action of hypoglycemic agents Andrea del Carmen Maldonado-Rojas; Julia María Zuarth-Vázquez; Misael Uribe; Varenka J Barbero-Becerra;

Dietary consumption and serum pattern of bioactive fatty acids in NAFLD patients Fabiola López-Bautista; Varenka J. Barbero-Becerra; María Yolanda Ríos; M. Ángeles Ramírez-Cisneros; Cristell A. Sánchez-Pérez; Martha H. Ramos-Ostos; Misael Uribe; Norberto C. Chávez-Tapia; Eva Juárez-Hernández;

Looking into a new era for the approach of metabolic (dysfunction) associated fatty liver disease Alejandro Valencia-Rodríguez; Alfonso Vera-Barajas; Norberto C. Chávez-Tapia; Misael Uribe; Nahum Méndez-Sánchez;